Recapping what I learned at HOPA 2026:
-Beyond steroids for irAs
-IT chemo beyond methotrexate and cytarabine
-Pre-emptive CMV management in patients receiving certain bispecifics
-semaglutide-alectinib drug interaction
-Safety (n = ~40) of MMR vaccine in patients post-Auto transplant on maintenance daratumumab

Check out the Oncology Insights Newsletter: www.kelleycpharmd.com/newsletter-oncopharm

Relacorilant

OncoPharm is a podcast dedicated to all things oncology pharmacy.  Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer.  Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.